Linear regression analysis for the prediction of the number of new cerebral infarcts
| Risk factor | Univariate analysis | |
| R | p Value | |
| Age | 0.37 | 0.042 |
| BMI (kg/m2) | 0.01 | 0.974 |
| EuroSCORE (Logistic) | −0.075 | 0.69 |
| AV Pressure gradient (mm Hg) | 0.11 | 0.57 |
| AV EOA (cm2) | −0.26 | 0.17 |
| LV ejection fraction (%) | 0.12 | 0.52 |
| LV EDD (mm) | −0.28 | 0.14 |
| Creatinine (μmol/l) | −0.02 | 0.90 |
| Hypertension | 0.19 | 0.30 |
| Hypercholesterolaemia | 0.11 | 0.55 |
| Diabetes | 0.1 | 0.59 |
| Atrial fibrillation | 0 | 0.93 |
| Cerebrovascular disease | 0.2 | 0.28 |
| Peripheral vascular disease | 0.06 | 0.73 |
| Porcelain aorta | 0.25 | 0.17 |
| Aortic atheroma ascending | 0.40 | 0.352 |
| Arch | 0.91 | <0.001 |
| Descending | 0.69 | 0.001 |
| Aortic calcification | 0.28 | 0.327 |
| Fluoroscopy time (min) | 0.36 | 0.05 |
| Catheterisation time (min) | 0.45 | 0.02 |
| Contrast dose (ml) | −0.12 | 0.53 |
| Heparin dose (U) | 0.24 | 0.19 |
AV, aortic valve; BMI, Body Mass Index; EDD, end-diastolic dimension; EOA, estimated orifice area; LV, left ventricular.